News

Filter

Current filters:

CiplaIndia

1 to 9 of 12 results

Medicines for Malaria Venture signs collaboration with Cipla and Strides Arcolab for rectal artesunate

Medicines for Malaria Venture signs collaboration with Cipla and Strides Arcolab for rectal artesunate

27-11-2014

The Medicines for Malaria Venture has signed collaboration agreements with Cipla and Strides Arcolab,…

Antibiotics and Infectious diseasesCiplaIndiaPharmaceuticalResearchStrides Arcolab

India’s Cipla calls for revocation of Novartis’ Onbrez patents

01-11-2014

Indian drugmaker Cipla has asked the government to revoke five patents that Swiss pharma major Novartis…

CiplaIndiaMarkets & MarketingNovartisOnbrezPatentsPharmaceuticalRespiratory and PulmonaryUnibrez

Cipla's generic of GSK's Advair for asthma marks expansion into Europe

Cipla's generic of GSK's Advair for asthma marks expansion into Europe

01-09-2014

Indian generic drugmaker Cipla has entered the respiratory market in Germany and Sweden with its Serroflo…

AdvairCiplaGenericsIndiaMarkets & MarketingRespiratory and Pulmonary

Indian Pharma increasing capital and research spending

Indian Pharma increasing capital and research spending

28-08-2014

With over $50 billion worth of drugs set to go off patent over the next two years in the USA, Indian…

CiplaDr Reddy's LaboratoriesFinancialGenericsGlenmark PharmaceuticalsIndiaLupinMergers & AcquisitionsResearchSun Pharmaceuticals

US regulatory warnings on drug producers extend well beyond India

US regulatory warnings on drug producers extend well beyond India

14-07-2014

Hauled up by the US Food and Drug Administration for product recalls and quality issues, Indian pharmaceutical…

CiplaDr Reddy's LaboratoriesGenericsIndiaLupinProductionRanbaxy LaboratoriesRegulationSun PharmaceuticalUSA

Cipla links with Hetero for biosimilar Aranesp; M&A in Yemen

30-06-2014

Cipla has collaborated with fellow Indian drugmaker Hetero to launch a biosimilar of the drug darbepoetin…

ActoriseAmgenAranespBiosimilarsCiplaGenericsHeteroIndiaMarkets & MarketingMergers & AcquisitionsOncologyRest of the World

Indian govt to penalize drugmakers for overcharging

Indian govt to penalize drugmakers for overcharging

06-05-2014

In a major crackdown, India's drug price regulator, the National Pharmaceutical Pricing Authority (NPPA)…

CiplaFinancialGlaxoSmithKlineIndiaPharmaceuticalPricing

1 to 9 of 12 results

Back to top